Hank Green talks with us about why research and development make the prescription drug development process long...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...
Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...
Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug molecules ...
The biggest challenge in drug development is that the process is not an even balance of hit or miss – it is overwhelmingly miss, with around 90% of drugs never making it beyond clinical trials. As a ...
The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors, and the general public. Researchers have ...
Chemists at Southwest Research Institute stumbled onto a purification breakthrough that could bring down discovery costs in drug research.
AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry challenges like the "patent cliff" and high clinical failure rates. AI-driven ...
The Costs They Are a-Rising: Commercialization Costs and the Innovation Process in Drug Development.
Khoshsokhan, Sina. The Costs They Are a-Rising: Commercialization Costs and the Innovation Process in Drug Development. Academy of Management Annual Meeting Proceedings. 2024, Vol. 2024 Issue 1, p1-6.
Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised $365 million in a late-stage funding. The company didn’t disclose the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results